Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001144204-08-034959

10% owner bought 20,000 shares at an average $4.34 ($86,708)

From the SEC's structured data for this filing

Trades in this filing

Trinad Capital Master Fund Ltd. · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2008-06-10 Purchase : show line 1 in the form +10,000 $4.31 $43,107 2,268,170 D
2008-06-11 Purchase : show line 2 in the form +10,000 $4.36 $43,601 2,278,170 D
Open-market purchases · 20,000 sh · avg $4.34 · $86,708
Loading xslF345X02/v117283_ex.xml…